in

HS&M™ TOP 100 HEALTHCARE COMPANIES

HEALTHCARE

Pharmaceutical, Medical Device and Biotechnology

Pc0250100

Creating one top healthcare list from our previous Top 50 Pharmaceutical, Medical Device and Biotechnology surveys proved quite interesting. With firms such as J&J that have products in more than one of the industry specialties, we had a total of 123 companies, which we narrowed to 100 for the consolidated list. These companies play a formidable role, with the revenue for 2014 totally over a trillion dollars, making up over 75% of the industry.

Pharmaceutical companies dominate in terms of revenue size. However, they’ve seen over 50% of their revenue decline year over year. At the same time, 70% of the top medical device and biotechnology companies are growing their revenues.

The results of the 2015 mergers and acquisitions will change the landscape for the next year’s lists. Medtronic/Covidien, Zimmer/ Biomet and CareFusion, Smith & Nephew/Arthrocare, St. Jude/ Thoratec, J&J divesting Ortho-Clinical Diagnostics, AbbVie/ Pharmacyclics, Pfizer/Hospira, Activis/Allergan, Valeant/Salix – the impact will be interesting. Had the Medtronic/Covidien acquisition happened in 2014 we would have seen our first medical device company reach the top 10. Covidien’s 2014 $10.66B in revenue, added to Medtronic’s $17.00B would have created a 27.66B stream, topping AstraZeneca’s $26.09B. The combined revenues would give Medtronic the highest medical technology revenues, exceeding J&Js ’s $27.52B in medical device Revenue.

The following list contains the top 100 firms in healthcare. Companies are ranked by their 2014 revenue as furnished by their annual reports and publicly available sources Edgar and Morningstar stock information websites (figures of non-U.S. companies were converted to U.S. dollars from various currencies using end-of-year exchange rates for 2014 and 2013). Total industry figures were obtained from EvaluateMedTech’s World Preview 2015 ($375B MedTech), IMS Health’s IMS Health Market Prognosis, May 2015 ($1,072B Pharmaceutical), IBIS’s Global Biotechnology Market Research Report, May 2015 ($312B).

Pc0270100
Pc0290000

CLICK HERE TO RECEIVE YOUR COPY OF THE TOP 100 HEALTH CARE COMPANIES

What do you think?

Written by hsandm

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Forecasting Pharma’s Future

Customized Customer Engagement